ibm-202606220000051143falseCHX00000511432026-06-222026-06-220000051143us-gaap:CommonStockMemberexch:XNYS2026-06-222026-06-220000051143us-gaap:CommonStockMemberexch:XCHI2026-06-222026-06-220000051143ibm:Notes0.300PercentDue2026Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes1.250PercentDue2027Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes3.375PercentDue2027Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes0.300PercentDue2028Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes1.750PercentDue2028Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes1.500PercentDue2029Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes0.875PercentDue2030Memberexch:XNYS2026-06-222026-06-220000051143ibm:A2.900NotesDue2030Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes1.750PercentDue2031Memberexch:XNYS2026-06-222026-06-220000051143ibm:A3.000NotesDue2031Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes3.625PercentDue2031Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes0.650PercentDue2032Memberexch:XNYS2026-06-222026-06-220000051143ibm:A3.150NotesDue2033Memberexch:XNYS2026-06-222026-06-220000051143ibm:A3.450NotesDue2034Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes1.250PercentDue2034Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes3.750PercentDue2035Memberexch:XNYS2026-06-222026-06-220000051143ibm:A3.450NotesDue2037Memberexch:XNYS2026-06-222026-06-220000051143ibm:A3.850NotesDue2038Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes4.875PercentDue2038Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes1.200PercentDue2040Memberexch:XNYS2026-06-222026-06-220000051143ibm:Notes4.000PercentDue2043Memberexch:XNYS2026-06-222026-06-220000051143ibm:A3.800NotesDue2045Memberexch:XNYS2026-06-222026-06-220000051143ibm:FloatingRateNotesDue2028Memberexch:XNYS2026-06-222026-06-220000051143ibm:Debentures6.22PercentDue2027Memberexch:XNYS2026-06-222026-06-220000051143ibm:Debentures6.50PercentDue2028Memberexch:XNYS2026-06-222026-06-220000051143ibm:Debentures5.875PercentDue2032Memberexch:XNYS2026-06-222026-06-220000051143ibm:Debentures7.00PercentDue2045Memberexch:XNYS2026-06-222026-06-220000051143ibm:Debentures7.125PercentDue2096Memberexch:XNYS2026-06-222026-06-22
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
FORM 8-K
CURRENT REPORT PURSUANT TO SECTION 13 OR 15 (d)
OF THE SECURITIES EXCHANGE ACT OF 1934
Date of Report: June 22, 2026
(Date of earliest event reported)
INTERNATIONAL BUSINESS MACHINES CORPORATION
(Exact name of registrant as specified in its charter)
| | | | | | | | | | | | | | |
| New York | | 1-2360 | | 13-0871985 |
| (State of Incorporation) | | (Commission File Number) | | (IRS employer Identification No.) |
| | | | | | | | | | | |
One New Orchard Road Armonk, New York | | | 10504 |
| (Address of principal executive offices) | | | (Zip Code) |
914-499-1900
(Registrant’s telephone number)
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:
| | | | | |
| ☐ | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
| ☐ | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
| ☐ | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
| ☐ | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Securities registered pursuant to Section 12(b) of the Act:
| | | | | | | | | | | | | | |
| Title of each class | | Trading symbol(s) | | Name of each exchange on which registered |
| Capital stock, par value $.20 per share | | IBM | | New York Stock Exchange |
| | | | NYSE Texas |
| 0.300% Notes due 2026 | | IBM 26B | | New York Stock Exchange |
| 1.250% Notes due 2027 | | IBM 27B | | New York Stock Exchange |
| 3.375% Notes due 2027 | | IBM 27F | | New York Stock Exchange |
| 0.300% Notes due 2028 | | IBM 28B | | New York Stock Exchange |
| 1.750% Notes due 2028 | | IBM 28A | | New York Stock Exchange |
| 1.500% Notes due 2029 | | IBM 29 | | New York Stock Exchange |
| 0.875% Notes due 2030 | | IBM 30A | | New York Stock Exchange |
| 2.900% Notes due 2030 | | IBM 30C | | New York Stock Exchange |
| 1.750% Notes due 2031 | | IBM 31 | | New York Stock Exchange |
| 3.000% Notes due 2031 | | IBM 31A | | New York Stock Exchange |
| 3.625% Notes due 2031 | | IBM 31B | | New York Stock Exchange |
| 0.650% Notes due 2032 | | IBM 32A | | New York Stock Exchange |
| 3.150% Notes due 2033 | | IBM 33A | | New York Stock Exchange |
| 3.450% Notes due 2034 | | IBM 34A | | New York Stock Exchange |
| 1.250% Notes due 2034 | | IBM 34 | | New York Stock Exchange |
| 3.750% Notes due 2035 | | IBM 35 | | New York Stock Exchange |
| 3.450% Notes due 2037 | | IBM 37 | | New York Stock Exchange |
| 3.850% Notes due 2038 | | IBM 38B | | New York Stock Exchange |
| 4.875% Notes due 2038 | | IBM 38 | | New York Stock Exchange |
| 1.200% Notes due 2040 | | IBM 40 | | New York Stock Exchange |
| 4.000% Notes due 2043 | | IBM 43 | | New York Stock Exchange |
| 3.800% Notes due 2045 | | IBM 45A | | New York Stock Exchange |
| Floating Rate Notes due 2028 | | IBM 28E | | New York Stock Exchange |
| 6.22% Debentures due 2027 | | IBM 27 | | New York Stock Exchange |
| 6.50% Debentures due 2028 | | IBM 28 | | New York Stock Exchange |
| 5.875% Debentures due 2032 | | IBM 32D | | New York Stock Exchange |
| 7.00% Debentures due 2045 | | IBM 45 | | New York Stock Exchange |
| 7.125% Debentures due 2096 | | IBM 96 | | New York Stock Exchange |
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).
Emerging growth company ☐
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐
Item 1.01. Entry into a Material Definitive Agreement.
On June 22, 2026, International Business Machines Corporation (“IBM”) (i) extended the maturity of the existing $2.5 billion Three-Year Credit Agreement dated as of June 22, 2021 (as amended by Amendment No. 1 to Three-Year Credit Agreement, dated as of June 30, 2022, and Amendment No. 2 to Three-Year Credit Agreement, dated as of June 20, 2025, the “Existing Three-Year Credit Agreement”), among IBM, the several banks and other financial institutions from time to time parties thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank N.A. and Royal Bank of Canada, as Syndication Agents, and the Documentation Agents named therein pursuant to an extension request as contemplated by the Existing Three-Year Credit Agreement and (ii) extended the maturity of the existing $7.5 billion Five-Year Credit Agreement dated as of June 22, 2021 (as amended by Amendment No. 1 to Five-Year Credit Agreement, dated as of June 30, 2022, and Amendment No. 2 to Five-Year Credit Agreement, dated as of June 20, 2025, the “Existing Five-Year Credit Agreement”), among IBM, the several banks and other financial institutions from time to time parties thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank N.A. and Royal Bank of Canada, as Syndication Agents, and the Documentation Agents named therein pursuant to an extension request as contemplated by the Existing Five-Year Credit Agreement.
The maturity of each of the Existing Three-Year Credit Agreement and the Existing Five-Year Credit Agreement was extended by a period of one year to June 20, 2029 and June 22, 2031, respectively, confirmations of which are filed as Exhibits 10.1 and 10.2 to this report, and are incorporated by reference herein. The terms of the Existing Three-Year Credit Agreement and the Existing Five-Year Credit Agreement otherwise remain unchanged.
Item 2.03. Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant.
The information set forth in Item 1.01 of this Current Report on Form 8-K is incorporated by reference herein.
Item 9.01. Financial Statements and Exhibits.
(d)Exhibits
| | | | | | | | |
| Exhibit No. | | Description of Exhibit |
| 10.1 | | Confirmation of Termination Date Extension dated June 22, 2026, to the $2,500,000,000 Three-Year Credit Agreement, dated as of June 22, 2021 (as amended by Amendment No. 1 to Three-Year Credit Agreement, dated as of June 30, 2022, and Amendment No. 2 to Three-Year Credit Agreement, dated as of June 20, 2025), among IBM, the several banks and other financial institutions from time to time parties thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank N.A. and Royal Bank of Canada, as Syndication Agents, and the Documentation Agents named therein |
| 10.2 | | Confirmation of Termination Date Extension dated June 22, 2026, to the $7,500,000,000 Five-Year Credit Agreement, dated as of June 22, 2021 (as amended by Amendment No. 1 to Five-Year Credit Agreement, dated as of June 30, 2022, and Amendment No. 2 to Five-Year Credit Agreement, dated as of June 20, 2025), among IBM, the several banks and other financial institutions from time to time parties thereto, JPMorgan Chase Bank, N.A., as Administrative Agent, BNP Paribas, Citibank N.A. and Royal Bank of Canada, as Syndication Agents, and the Documentation Agents named therein |
| 104 | | Cover Page Interactive Data File (embedded within the Inline XBRL Document) |
SIGNATURE
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, hereunto duly authorized.
| | | | | | | | |
| Date: June 23, 2026 | |
| | |
| By: | /s/ Brien Wierzchowski |
| | Brien Wierzchowski |
| | Vice President and Treasurer |
